South San Francisco, CA, United States of America

Jeffrey R Spencer


Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • San Mateo, CA (US) (2003)
  • South San Francisco, CA (US) (2005 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey R. Spencer: A Pioneer in Erythropoietin-Mimetic Compounds

Introduction

Jeffrey R. Spencer is an accomplished inventor based in South San Francisco, CA, known for his significant contributions to the field of biotechnology. With a total of six patents, his work primarily focuses on compounds that enhance cell proliferation, differentiation, and survival, particularly in erythropoietin-responsive cells.

Latest Patents

Among Jeffrey R. Spencer's latest innovations are two notable patents concerning substituted triazolo-pyrimidine compounds. These erythropoietin-mimetic compounds are disclosed in detail, demonstrating their ability to modulate the survival, function, or differentiation of kidney cells, neurons, erythroid cells, and other cells that respond to erythropoietin. These inventions hold promise for advancing treatments for conditions such as anemia, organ injuries, and diseases affecting the central nervous system. Furthermore, they may serve as adjuncts to cellular treatments like stem cell therapies.

Career Highlights

Throughout his career, Spencer has collaborated with notable companies, including Strategics, Inc. and Axys Pharmaceuticals, Inc. His work in these innovative firms has allowed him to further his understanding and application of biopharmaceuticals, translating research into valuable medical advancements.

Collaborations

In addition to his work at various companies, Jeffrey R. Spencer has collaborated with esteemed colleagues such as Juha Punnonen and Timothy J. Church. Their joint efforts have fostered the development of groundbreaking technologies in the realm of cell biology and therapeutic applications.

Conclusion

Jeffrey R. Spencer's contributions through his patents exemplify the critical role of innovation in medicine and biotechnology. His focus on erythropoietin-mimetic compounds signifies a forward-thinking approach towards combating diseases and enhancing cellular health. As researchers and companies continue to build upon his foundational work, the potential for new treatments remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…